Medical Device News Magazine

WellSky to Deliver In-Home Protocols for Patients With Heart Failure

WellSky’s technology platform and provider networks will coordinate the execution of in-home, heart failure protocols to lower hospital readmissions at The Ohio State University Wexner Medical Center

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

WellSky, a leading health and community care technology company, today announced they will work with The Ohio State University Wexner Medical Center to implement in-home, heart failure care protocols that are intended to reduce hospital readmissions for patients discharged after admission for heart failure.

Heart failure is a leading cause of hospital readmission in the United States, with an average 30-day readmission rate of nearly 25 percent, generating more than one million hospital stays annually.

The WellSky Care Coordination platform and network of personal care and home health providers coordinates the delivery of care to heart failure patients who are voluntarily enrolled in the program at the time of hospital discharge. The WellSky protocols leverage cutting-edge ReDS™ technology, a system that can view the inside of the lungs of heart failure patients. Using this technology from Sensible Medical, clinicians can quickly and accurately assess lung fluid in heart failure patients, enabling the deployment of customized care interventions that are intended to prevent hospital readmissions.

Dr. Dan Bensimhon, a Medical Director of WellSky and Medical Director of Cone Health’s Advanced Heart Failure Clinic, a national leader in designing heart failure care at-home pathways, has been instrumental in designing these protocols. In applying the protocols in multiple health systems across North Carolina, Dr. Bensimhon has realized a 40 percent decrease in readmission rates. In a meta-analysis comprised of seven published clinical studies, researchers found a 60 percent reduction in heart failure readmission rates on average when using the ReDS technology, as compared to standard post-discharge heart failure care.

This new, transformational program powers collaboration between heart failure cardiologists, telehealth clinicians, nurses, and personal caregivers to optimize the care of these patients in the home. Dr. Brent Lampert and Dr. Raymond Benza will lead the program at Ohio State Wexner Medical Center.

“WellSky is excited to work with Dr. Lampert and Dr. Benza on the implementation of this innovative protocol that enables advanced clinical and operational workflows for complex care delivery,” said Bill Miller, WellSky CEO. “By integrating care coordination technology and scaled, connected provider networks, hospital systems can deliver improved outcomes through coordinated condition-specific protocols.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”